Sök artiklar i SveMed+

Observera: SveMed+ upphör att uppdateras!



Substitutionsbehandlingens genombrott i finland
Engelsk titel: The breakthrough of the Finnish substitution treatment Läs online Författare: Hakkarainen P ; Tigerstedt C Språk: Swe Antal referenser: 58 Dokumenttyp: Artikel UI-nummer: 05113690

Tidskrift

Nordisk Alkohol- & Narkotikatidskrift 2005;22(3-4)249-66 ISSN 1455-0725 E-ISSN 1458-6126 KIBs bestånd av denna tidskrift Denna tidskrift är expertgranskad (Peer-Reviewed)

Sammanfattning

AIMS: Official records indicate that in 1996 no more than fi ve drug addicts in Finland received medically assisted treatment. By 2004 that fi gure had grown to 600- 700 persons. This article retraces the path to this crucial change. DESIGN: Several factors of this change are scrutinised. In the latter part of the 1990s, Finland saw a signifi cant increase in drug-related harms, resulting in a gradual revision of drug policies. Medically assisted treatment was brought under the spotlight through serious public controversies, centred on two private doctors prescribing buprenorphine for their heroin-using patients. Claims-makers, representing a variety of agencies, stood up for substitution treatment. International trends in substitution treatment, as well as scientifi c research, facilitated the advocacy of such treatment. RESULTS: The drug user has been redefi ned in terms of private and public health, and civil rights, engendering a more liberal attitude towards substitution treatment. National drug policy is characterised by a joint move: social and health policy initiatives, on the one hand, and criminal policy, on the other, are running on separate tracks, making it possible to increase control powers and to expand treatment services. CONCLUSIONS: Several questions are still unresolved. For example, there has been very little debate on the widely known problem of buprenorphine abuse.